To facilitate the exchange of information among the global community of dermatologists, the XIth Congress of International Society of Dermatology was held in New Delhi between December 4-7, 2013. A number of oustanding speakers discussed the state of the art in vitiligo management, such as Professors Jana Hercogova, Torello Lotti, Paulo Cunha, Koushik Lahiri, Somesh Gupta, Kanika Sahni, T Salim, Davinder Parsad, among many. Yan Valle, the VR Foundations CEO, gave a detailed presentation on our multidisciplinary approach to an expedited development of drugs for the treatment of vitiligo.
- Shall I take vitamin D for my vitiligo?
In Brief Vitamin D plays a central role in the prevention of different inflammatory and chronic diseases. Consuming 1,000–4,000 IU (25–100 mcg) of vitamin D3 daily should be id...
- I have a new job - should I tell colleagues about my vitiligo?
If you are starting a new job and you are concerned about stares and questions about your skin, try a proactive approach. When the time is right and you are feeling comfortable,...
- Which diseases most commonly accompany vitiligo?
According to a 10-year study, vitiligo patients have a statistically significant higher prevalence of other autoimmune conditions and dermatological disorders: hypothyroidism...
Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.Copyright (C) Bodolóczki Júlia
By taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.